Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction-Reference-Cited by-同舟云学术

Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction

Published:2023-05 Issue: Volume:378 Page:55-63
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Nishino Masami,Egami Yasuyuki,Kawanami Shodai,Sugae Hiroki,Ukita Kohei,Kawamura Akito,Nakamura Hitoshi,Yasumoto Koji,Tsuda Masaki,Okamoto Naotaka,Matsunaga-Lee Yasuharu,Yano Masamichi,Tanouchi Jun,Yamada Takahisa,Yasumura Yoshio,Seo Masahiro,Tamaki Shunsuke,Hayashi Takaharu,Nakagawa Akito,Nakagawa Yusuke,Sotomi Yohei,Nakatani Daisaku,Hikoso Shungo,Sakata Yasushi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Polypharmacy in heart failure patients;Mastromarino;Curr. Heart. Fail. Rep.,2014

2. Characteristics of hospitalizations for heart failure with preserved ejection fraction;Goyal;Am. J. Med.,2016

3. Spironolactone for heart failure with preserved ejection fraction;Pitt;N. Engl. J. Med.,2014

4. Empagliflozin in heart failure with a preserved ejection fraction;Anker;N. Engl. J. Med.,2021

5. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial;Nassif;Nat. Med.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cardiovascular polypharmacy perspective on octogenarians with HFpEF;International Journal of Cardiology;2023-07

2. Will computerised medical records and statistical tools really help us move towards precision medicine of heart failure with preserved ejection fraction?;Heart;2023-04-17